OVID
NASDAQ · Biotechnology
Ovid Therapeutics Inc
$2.40
-0.14 (-5.51%)
Analyst Consensus
Strong Buy
19
Analysts
High
Coverage
Price Target
Analyst Price Target
+1,610.0% upside
Low Target
$30.97
Average Target
$41.04
High Target
$66.83
Current Price
$2.40
Current
$2.40
$2.40
Target
$41.04
$41.04
$30.97
$41.04 avg
$66.83
Scenario Analysis
Bear Case
$30.97
1,190.4%
Low target
Base Case
$41.04
+1,610.0%
Avg target
Bull Case
$66.83
+2,684.6%
High target
Risk/Reward
2.3x
Favorable
Price in Context
52-Week High
$3.11
-22.7% from high
52-Week Low
$1.18
+103.4% from low
50-Day SMA
$2.50
-4.0% vs SMA
200-Day SMA
$2.42
-0.8% vs SMA
RSI (14)
54.1
Neutral
Target vs 52W High
$41.04
+1,221.7% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 38 | 82% | $257.58 | -12.6% |
| AMGN | Hold | 42 | 43% | $190.87 | -58.2% |
| GILD | Strong Buy | 36 | 83% | $362.68 | +114.1% |
| VRTX | Strong Buy | 39 | 82% | $438.34 | -17.6% |
| REGN | Buy | 36 | 72% | $76.80 | -91.9% |
| MRNA | Hold | 31 | 32% | $149.45 | -30.6% |
| NTRA | Strong Buy | 31 | 90% | $142.91 | -50.5% |
| RVMD | Strong Buy | 31 | 94% | $114.11 | -31.6% |